| PERIOD ENDING | 11-Mar-09 | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 300,315 | 300,315 | 313,918 | | Cost of Revenue | 96,091 | 96,091 | 97,080 | | | Gross Profit | 204,224 | 204,224 | 216,838 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 160,072 | 82,999 | 77,016 | | Non Recurring |
-
| 77,073 |
-
| | Others | 126,430 | 126,430 | 12,337 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (82,278) | (82,278) | 127,485 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (82,278) | (82,278) | 127,485 | | Interest Expense | 16,094 | 16,094 | 15,961 | | Income Before Tax | (98,372) | (98,372) | 111,524 | | Income Tax Expense | (8,635) | (8,635) | 37,586 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (89,737) | (89,737) | 73,938 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (89,737) | (89,737) | 73,938 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($89,737) | ($89,737) | $73,938 |
|
0.34% Nasdaq 
Income Statement
